Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Dimethyltryptamine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    atai Life Sciences Announces First Subject Dosed in Phase 1 Trial
    atai Life Sciences Announces First Subject Dosed in Phase 1 Trial

    05 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/05/2528522/0/en/atai-Life-Sciences-Announces-First-Subject-Dosed-in-Phase-1-Trial-of-Buccal-and-IV-VLS-01-a-Synthetic-Form-of-DMT.html

    GLOBENEWSWIRE
    05 Oct 2022
    Share Share
    Core One Labs' Scientists Successfully Complete Breakthrough in Producing API
    Core One Labs' Scientists Successfully Complete Breakthrough in Producing API

    02 Sep 2022

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=714615

    ACCESSWIRE
    02 Sep 2022
    Share Share
    Cybin completes purchase of anxiety disorder treatment study
    Cybin completes purchase of anxiety disorder treatment study

    12 Jul 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/cybin-anxiety-disorder-treatment-study/

    CLINICALTRIALSARENA
    12 Jul 2022
    Share Share
    Small Pharma Reports Fiscal Third Quarter 2021 Highlights
    Small Pharma Reports Fiscal Third Quarter 2021 Highlights

    31 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/31/2376167/0/en/Small-Pharma-Reports-Fiscal-Third-Quarter-2021-Highlights.html

    GLOBENEWSWIRE
    31 Jan 2022
    Share Share
    Algernon Discloses Novel Salt Patent Strategy as Part of Psychedelic Drug DMT IP
    Algernon Discloses Novel Salt Patent Strategy as Part of Psychedelic Drug DMT IP

    24 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/24/2371542/0/en/Algernon-Pharmaceuticals-Discloses-Novel-Salt-Patent-Strategy-as-Part-of-its-Psychedelic-Drug-DMT-Intellectual-Property.html

    GLOBENEWSWIRE
    24 Jan 2022
    Share Share
    Algernon Files for Trial and Ethics Approval for Phase 1 DMT Human Stroke Study
    Algernon Files for Trial and Ethics Approval for Phase 1 DMT Human Stroke Study

    19 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/19/2369181/0/en/Algernon-Pharmaceuticals-Files-for-Clinical-Trial-and-Ethics-Approval-for-Phase-1-DMT-Human-Stroke-Study.html

    GLOBENEWSWIRE
    19 Jan 2022
    Share Share